About Nuvation Bio
Nuvation Bio is a clinical-stage biopharmaceutical company developing cancer therapeutics targeting treatment-resistant tumors with novel small molecule inhibitors.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Nuvation Bio. Response typically within 48 hours.
Company Info
TypePublic
StockNUVB (NYSE)
Founded2018
Employees180
Revenue$28M
HQNew York, USA
